Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy.
Thirty-two eyes of 32 patients were treated with 0.5% timolol, 2% pilocarpine, or normal saline five and 30 minutes following neodymium-YAG laser posterior capsulotomy in a randomized, double-masked study. Mean maximum intraocular pressure (IOP) elevation was 8 +/- 2 mm Hg following treatment with normal saline, 5 +/- 3 mm Hg following treatment with 2% pilocarpine, and 1 +/- 2 mm Hg following treatment with 0.5% timolol. Fewer patients treated with 0.5% timolol developed an IOP elevation of 5 mm Hg or more than control patients. On aphakic patient treated with 0.5% timolol developed a maximum IOP greater than or equal to 40 mm Hg. We found that treatment with 0.5% timolol after neodymium-YAG laser posterior capsulotomy provides partial protection from IOP elevation.
D000368:Aged; D005069:Evaluation Studies as Topic; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D053685:Laser Therapy; D007903:Lens Capsule, Crystalline / Q000601:surgery*; D007908:Lens, Crystalline / Q000601:surgery*; D008875:Middle Aged; D010862:Pilocarpine / Q000627:therapeutic use*; D011182:Postoperative Care; D013999:Timolol / Q000627:therapeutic use*
D010862:Pilocarpine; D013999:Timolol